Business Wire - February 02, 2012
- Fourth Quarter Product Sales of $2.13 Billion, up 11% Year over
- Full Year 2011 Product Sales of $8.10 Billion, up 10% over 2010 -
- Full Year 2011 Non-GAAP EPS of $3.86, up 5% over 2010 -
- Full Year 2011 Operating Cash Flows of $3.64 Billion -
FOSTER CITY, Calif. - Gilead Sciences, Inc.
(Nasdaq:GILD) announced today its results of operations for the
fourth quarter and full year 2011. Total revenues for the fourth
quarter of 2011 increased 10 percent to $2.20 billion, from $2.00
billion for the fourth quarter of 2010. Net income for the fourth
quarter of 2011 was $665.1 million, or $0.87 per diluted share,
compared to $629.4 million, or $0.76 per diluted share for the
fourth quarter of 2010. Non-GAAP net income for the fourth
quarter of 2011, which excludes after-tax acquisition-related,
restructuring and stock-based compensation expenses, was $743.1
million, or $0.97 per diluted share, compared to $779.3 million,
or $0.95 per diluted share for the fourth quarter of 2010.
Please click here[http://www.businesswire.com/news/home/20120202006589/en/Gilead-Sciences-Announces-Fourth-Quarter-Full-Year] to access the
full press release.